Clinical Trial Update: A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of dasatinib in patients with chronic phase Philadelphia chromosome-positive chronic myeloid leukemia has completed; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myeloid Leukemia, Chronic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-11-30